Advancing research in autoimmune neuromuscular disorders

Affiliations

Comment

Donald B Sanders. Lancet Neurol. 2022 Feb.

. 2022 Feb;21(2):108-110.

doi: 10.1016/S1474-4422(21)00469-5.

¹ Duke University Medical Center, Durham, NC 27710, USA. Electronic address: donald.sanders@duke.edu.

No abstract available

Comment on

Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders.
Huijbers MG, Marx A, Plomp JJ, Le Panse R, Phillips WD. Huijbers MG, et al. Lancet Neurol. 2022 Feb;21(2):163-175. doi: 10.1016/S1474-4422(21)00357-4. Lancet Neurol. 2022. PMID: 35065039 Review.
Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders.
Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Punga AR, et al. Lancet Neurol. 2022 Feb;21(2):176-188. doi: 10.1016/S1474-4422(21)00297-0. Lancet Neurol. 2022. PMID: 35065040 Review.
Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders.
Verschuuren JJ, Palace J, Murai H, Tannemaat MR, Kaminski HJ, Bril V. Verschuuren JJ, et al. Lancet Neurol. 2022 Feb;21(2):189-202. doi: 10.1016/S1474-4422(21)00463-4. Lancet Neurol. 2022. PMID: 35065041 Review.